Notify me when BAKER BROS. ADVISORS LP files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 90 | $13,838,782,047 | +$587,941,651 | -$248,883,606 | +$339,058,045 | ONC, INCY, MDGL, INSM, ACAD | 13F-HR | 14 Nov 2025, 16:27 |
| Q2 2025 | 88 | $10,307,840,459 | +$977,935,575 | -$253,917,055 | +$724,018,520 | ONC, INCY, ACAD, INSM, SMMT | 13F-HR | 14 Aug 2025, 16:04 |
| Q1 2025 | 88 | $9,036,702,464 | +$206,153,924 | -$422,302,510 | -$216,148,586 | ONC, INCY, ACAD, MDGL, SMMT | 13F-HR | 15 May 2025, 16:37 |
| Q4 2024 | 95 | $9,361,492,374 | +$290,678,217 | -$238,641,151 | +$52,037,066 | INCY, ONC, ACAD, MDGL, SMMT | 13F-HR | 14 Feb 2025, 16:12 |
| Q3 2024 | 93 | $9,648,757,562 | +$238,933,420 | -$134,135,269 | +$104,798,151 | BGNE, INCY, ACAD, SMMT, MDGL | 13F-HR | 14 Nov 2024, 16:07 |
| Q2 2024 | 95 | $7,825,077,664 | +$925,327,808 | -$625,739,735 | +$299,588,073 | INCY, BGNE, ACAD, MDGL, RVMD | 13F-HR | 14 Aug 2024, 16:05 |
| Q1 2024 | 87 | $7,971,707,022 | +$381,595,188 | -$510,522,774 | -$128,927,586 | INCY, BGNE, ACAD, MDGL, RYTM | 13F-HR | 15 May 2024, 16:37 |
| Q4 2023 | 84 | $8,788,600,529 | +$625,006,269 | -$10,310,460,597 | -$9,685,454,328 | INCY, BGNE, ACAD, MDGL, RYTM | 13F-HR | 14 Feb 2024, 17:12 |
| Q3 2023 | 101 | $17,351,037,330 | +$187,409,158 | -$321,794,593 | -$134,385,435 | SGEN, BGNE, INCY, ACAD, BMRN | 13F-HR | 14 Nov 2023, 16:25 |
| Q2 2023 | 107 | $17,279,240,811 | +$436,731,637 | -$522,375,105 | -$85,643,468 | SGEN, INCY, BGNE, ACAD, MDGL | 13F-HR | 14 Aug 2023, 16:13 |
| Q1 2023 | 105 | $18,379,748,932 | +$254,540,219 | -$1,250,571,428 | -$996,031,209 | SGEN, INCY, BGNE, ACAD, MDGL | 13F-HR | 15 May 2023, 16:04 |
| Q4 2022 | 113 | $16,651,382,602 | +$272,311,014 | -$570,653,174 | -$298,342,160 | SGEN, INCY, BGNE, BMRN, ACAD | 13F-HR | 14 Feb 2023, 16:06 |
| Q3 2022 | 115 | $15,255,622,837 | +$269,529,584 | -$588,916,340 | -$319,386,756 | SGEN, INCY, BGNE, ACAD, BMRN | 13F-HR | 14 Nov 2022, 16:06 |
| Q2 2022 | 117 | $17,612,451,550 | +$251,944,928 | -$198,870,592 | +$53,074,336 | SGEN, INCY, BGNE, BMRN, ACAD | 13F-HR | 15 Aug 2022, 16:56 |
| Q1 2022 | 118 | $17,403,462,000 | +$346,995,695 | -$107,053,188 | +$239,942,507 | SGEN, INCY, BGNE, ACAD, BMRN | 13F-HR | 16 May 2022, 16:05 |
| Q4 2021 | 121 | $20,553,592,000 | +$386,028,837 | -$191,439,324 | +$194,589,513 | SGEN, BGNE, INCY, KOD, ACAD | 13F-HR | 14 Feb 2022, 16:09 |
| Q3 2021 | 122 | $22,765,959,000 | +$594,100,300 | -$306,685,839 | +$287,414,461 | SGEN, BGNE, INCY, KOD, ASND | 13F-HR | 15 Nov 2021, 15:58 |
| Q2 2021 | 120 | $22,769,898,000 | +$487,581,755 | -$972,268,076 | -$484,686,321 | SGEN, BGNE, INCY, KOD, ACAD | 13F-HR | 16 Aug 2021, 16:11 |
| Q1 2021 | 126 | $23,065,323,000 | +$741,471,420 | -$871,486,468 | -$130,015,048 | SGEN, BGNE, INCY, KOD, ACAD | 13F-HR | 17 May 2021, 16:03 |
| Q4 2020 | 126 | $26,543,637,000 | +$1,155,389,631 | -$1,250,862,363 | -$95,472,732 | SGEN, BGNE, INCY, ACAD, KOD | 13F-HR | 16 Feb 2021, 15:59 |
| Q3 2020 | 120 | $25,025,928,000 | +$10,407,779,701 | -$8,324,818,232 | +$2,082,961,469 | SGEN, BGNE, INCY, ACAD, ALXN | 13F-HR | 16 Nov 2020, 16:00 |
| Q2 2020 | 114 | $22,670,991,000 | +$621,956,861 | -$795,585,889 | -$173,629,028 | SGEN, INCY, BGNE, ACAD, ALXN | 13F-HR | 14 Aug 2020, 16:08 |
| Q1 2020 | 110 | $16,236,233,000 | +$318,438,853 | -$144,874,018 | +$173,564,835 | SGEN, INCY, ACAD, BGNE, ALXN | 13F-HR | 15 May 2020, 16:03 |
| Q4 2019 | 99 | $18,809,854,000 | +$688,640,780 | -$1,121,869,451 | -$433,228,671 | SGEN, INCY, BGNE, ACAD, ALXN | 13F-HR | 14 Feb 2020, 16:26 |
| Q3 2019 | 109 | $14,699,689,000 | +$343,408,089 | -$273,420,355 | +$69,987,734 | SGEN, INCY, ACAD, BGNE, ALXN | 13F-HR | 14 Nov 2019, 16:05 |
| Q2 2019 | 103 | $14,714,211,000 | +$307,737,016 | -$653,132,708 | -$345,395,692 | SGEN, INCY, BGNE, ALXN, ACAD | 13F-HR | 14 Aug 2019, 16:01 |
| Q1 2019 | 96 | $15,621,759,000 | +$258,147,269 | -$245,406,276 | +$12,740,993 | SGEN, INCY, BGNE, ALXN, ACAD | 13F-HR | 15 May 2019, 16:06 |
| Q4 2018 | 93 | $12,212,527,000 | +$525,605,684 | -$491,723,294 | +$33,882,390 | SGEN, INCY, BGNE, ALXN, GHDX | 13F-HR | 13 Feb 2019, 16:14 |
| Q3 2018 | 97 | $15,181,170,000 | +$452,545,359 | -$604,627,307 | -$152,081,948 | SGEN, INCY, BGNE, ALXN, GHDX | 13F-HR | 14 Nov 2018, 15:50 |
| Q2 2018 | 119 | $13,308,802,000 | +$1,493,436,245 | -$473,867,975 | +$1,019,568,270 | SGEN, INCY, BGNE, ALXN, BMRN | 13F-HR | 14 Aug 2018, 15:48 |
| Q1 2018 | 114 | $11,797,988,000 | +$817,631,737 | -$324,985,643 | +$492,646,094 | INCY, SGEN, BGNE, ALXN, BMRN | 13F-HR | 15 May 2018, 15:47 |
| Q4 2017 | 123 | $11,537,077,000 | +$715,796,247 | -$306,026,924 | +$409,769,323 | INCY, SGEN, ALXN, ACAD, BMRN | 13F-HR | 14 Feb 2018, 15:49 |
| Q3 2017 | 121 | $12,330,918,000 | +$271,474,810 | -$98,384,125 | +$173,090,685 | INCY, SGEN, ALXN, ACAD, BMRN | 13F-HR | 14 Nov 2017, 15:45 |
| Q2 2017 | 120 | $11,409,449,000 | +$419,604,974 | -$237,610,556 | +$181,994,418 | INCY, SGEN, ALXN, ACAD, BMRN | 13F-HR | 14 Aug 2017, 15:48 |
| Q1 2017 | 119 | $12,220,691,000 | +$1,552,644,973 | -$1,266,877,191 | +$285,767,782 | INCY, SGEN, ACAD, ALXN, GHDX | 13F-HR | 15 May 2017, 16:00 |
| Q4 2016 | 133 | $10,200,965,000 | +$301,990,877 | -$1,029,878,979 | -$727,888,102 | SGEN, INCY, ALXN, ACAD, GHDX | 13F-HR | 14 Feb 2017, 16:13 |
| Q3 2016 | 134 | $11,019,928,000 | +$268,439,497 | -$280,641,562 | -$12,202,065 | SGEN, INCY, ABBV, ACAD, ALXN | 13F-HR | 14 Nov 2016, 17:30 |
| Q2 2016 | 135 | $9,537,918,000 | +$84,954,478 | -$543,720,940 | -$458,766,462 | INCY, SGEN, ABBV, ACAD, ALXN | 13F-HR | 15 Aug 2016, 16:07 |
| Q1 2016 | 134 | $9,476,562,000 | +$970,134,635 | -$379,773,393 | +$590,361,242 | INCY, SGEN, ALXN, ABBV, ACAD | 13F-HR | 16 May 2016, 16:12 |
| Q4 2015 | 133 | $12,071,272,000 | +$479,244,769 | -$139,567,076 | +$339,677,693 | INCY, SGEN, ALXN, ABBV, ACAD | 13F-HR | 16 Feb 2016, 16:52 |
| Q3 2015 | 133 | $10,823,762,000 | +$1,447,730,363 | -$710,330,344 | +$737,400,019 | INCY, SGEN, ALXN, ABBV, ACAD | 13F-HR | 16 Nov 2015, 16:07 |
| Q2 2015 | 126 | $11,400,413,000 | +$2,515,703,920 | -$4,423,424,556 | -$1,907,720,636 | INCY, SGEN, ALXN, ABBV, ACAD | 13F-HR | 14 Aug 2015, 16:19 |
| Q1 2015 | 130 | $12,022,854,000 | +$633,039,418 | -$870,619,111 | -$237,579,693 | PCYC, INCY, GEVA, SGEN, ACAD | 13F-HR | 15 May 2015, 16:06 |
| Q4 2014 | 121 | $9,797,154,000 | +$882,162,320 | -$134,076,818 | +$748,085,502 | PCYC, INCY, GEVA, SGEN, AVNR | 13F-HR | 17 Feb 2015, 16:15 |
| Q3 2014 | 107 | $7,828,989,000 | +$269,843,708 | -$531,986,140 | -$262,142,432 | PCYC, SGEN, GEVA, INCY, ACAD | 13F-HR | 14 Nov 2014, 16:51 |
| Q2 2014 | 106 | $8,164,077,000 | +$448,766,185 | -$373,136,860 | +$75,629,325 | GEVA, PCYC, SGEN, INCY, ACAD | 13F-HR | 14 Aug 2014, 16:15 |
| Q1 2014 | 108 | $7,867,925,000 | +$656,287,181 | -$434,702,924 | +$221,584,257 | SGEN, GEVA, PCYC, INCY, ACAD | 13F-HR | 15 May 2014, 16:10 |
| Q4 2013 | 95 | $7,095,729,000 | $0 | $0 | $0 | PCYC, SGEN, INCY, GEVA, ACAD | 13F-HR | 14 Feb 2014, 16:21 |